1.778.600.0509
Advancing the Paradigm of Patient Care

Two
Industry-Leading
Technologies

ASEP offers a rare combination of both a novel diagnostic and a therapeutic approach to a multibillion-dollar problem.

Diagnostic

The problem:

Delayed diagnosis.

Blood cultures take 24 hours for results. Every hour delay in diagnosis and appropriate treatment increases the probability of death 7.6%.

The solution:

Gene-signature-
based test.

Provides reliable diagnosis in 1 hour, with more sensitivity and specificity than the SIRS or Sepsis 3 criteria used today.

Therapeutic

The problem:

Ineffective treatment

Biofilms are associated with 65% of all infections. There is currently no effective treatment.

The solution:

Proprietary peptide technology.

Provides broad spectrum efficacy against bacteria growing antibiotic-resistant biofilms.

CSE: ASEP | OTCQB: SEPSF
This is default text for notification bar